0001144204-13-049226.txt : 20130904
0001144204-13-049226.hdr.sgml : 20130904
20130904163030
ACCESSION NUMBER: 0001144204-13-049226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130830
FILED AS OF DATE: 20130904
DATE AS OF CHANGE: 20130904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YETTER JOHN E
CENTRAL INDEX KEY: 0001240335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 131078226
MAIL ADDRESS:
STREET 1: DERMA SCIENCES INC
STREET 2: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
v354363_4.xml
OWNERSHIP DOCUMENT
X0306
4
2013-08-30
0
0000892160
DERMA SCIENCES, INC.
DSCI
0001240335
YETTER JOHN E
DERMA SCIENCES INC
214 CARNEGIE CENTER, SUITE 300
PRINCETON
NJ
08540
0
1
0
0
EVP, Finance & CFO
Common Stock
2013-08-30
4
S
0
500
14.01
D
58384
D
Common Stock
2013-09-03
4
S
0
11600
14.17
D
46784
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan.
Represents the weighted average sale price of multiple transactions with a range of prices between $14.00 to $14.05. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of multiple transactions with a range of prices between $14.00 to $14.30. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ John E. Yetter
2013-09-04